Hide

FocusBar

Subscribe to Premium Member
Free 7-day Trial
All Articles and Columns »

Ingram Micro – Q2 beats and full year estimates rise

August 03, 2010 | About:
Dr. Paul Price

Dr. Paul Price

35 followers
IM [$16.91] showed $0.41 for their June quarter versus $0.20 in 2009 and guided for $0.41 for Q3 against last year’s $0.29. Zacks recently raised it full year EPS goal to $1.87 /share. Current expectations for 2011 are running $2.07. That puts IM’s multiple at just 9x this year’s and 8.2x 2011’s earnings – about the lowest valuations ever for this world leader in wholesale distribution of computer products and services.



The shares bottomed below $15 just a few weeks ago and now are in a clear uptrend again. With both the 2010 and 2011 estimates at all-time record levels I see no reason why IM can’t exceed its old highs from 2004 – 2008 when it peaked each year between $20 and $22.50.

I’m willing to play for a move to at least $20 by March 19, 2011 by putting on this buy/write combination:

Cash Outlay Cash Inflow
Buy 1000 IM for $16.91 /share $16,910
STO 10 Mar. $20 calls at $0.40 /share $400
STO 10 Mar. $20 puts at $3.40 /share $3,400
Net Cash Out-of-Pocket $13,110


If Ingram Micro moves up to $20 or better [+18.3%] by March 19, 2011:

· The calls will be exercised and the puts will expire.

· You will sell your shares for $20,000.

This best-case scenario would result in a profit of $20,000 - $13,110 = $6,890.

$6,890/$13,110 = + 52.5%

Achieved in just 7.5 months on shares that only needed to rise by at 18.3%.



If IM remains below $20 on March 19, 2011 you’ll end up with 2000 shares of Ingram at an average cost basis of $16.56 /share – a 2.06% discount to the August 2nd closing price.



More conservative investors could buy the shares while writing the March 2011 $17.50 calls and puts.

Cash Outlay Cash Inflow
Buy 1000 IM for $16.91 /share $16,910
STO 10 Mar. $17.50 calls at $1.20 /sh. $1,200
STO 10 Mar. $17.50 puts at $1.70 /sh. $1,700
Net Cash Out-of-Pocket $14,010


In this case any move up to $17.50 or higher [+3.5%] by March 19, 2011 would see the calls exercised and the puts expiring.

The profit would be $17,500 - $14,010 = $3,490.

$3,490/$14,010 = + 24.9% achieved on any rise of 3.5% or better over the 7 ½ month time horizon for this trade.

Should IM fail to finish above $17.50 you’ll end up owning 2000 IM at an average cost of $15.76 or 6.8% below our trade inception price.



Disclosure: Author is long IM shares and short IM options.

Dr. Paul Price

www.OptionsProfits.com

www.BeatingBuffett.com

About the author:

Dr. Paul Price: After college at The American University [BS - 1971] and dental school at University of Pennsylvania [DMD - 1977] Paul served as a dental officer in the United States Air Force both domestically and overseas in Turkey and England. In 1987 he made a full-time career switch by joining Merrill Lynch. Over the next 13 years he also worked with A.G. Edwards, Wheat First [now Wachovia Securities], and Ferris, Baker Watts. Dr. Price had enough success to retire in October 2000 but continues to help friends and family with their investments. He continues to give occasional investment seminars for civic groups and business schools.

Tickers in the article:

A Screener Endorsed by Warren Buffett without Knowing

In a recent interview Warren Buffett mentioned three companies that he finds attractive. Out of the three companies he mentioned, two of them are listed in GuruFocus’ Buffett-Munger screener. Buffett-Munger Screener looks for high quality companies that are traded at fair prices, the kind of companies that Buffett buys and hold forever. The Model Portfolio of Buffett-Munger Screener has outperformed the market year-over-year. It is just one of the features provided with GuruFocus Premium Membership.

Click Here to Try It Free!


Rating: 3.8/5 (4 votes)

Comments

Please leave your comment:


More Gurufocus Links

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK

This article has been successfully added into your Bookmark.

Members Only. Please Sign Up or Log In first.

Bookmark of this article has been deleted.